The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...

A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while ...

Controlling the entire cell therapy production process—from material receipt to product release—is “essential,” according to AstraZeneca, which says its new $300 million manufacturing facility will be ...

Harvey Jones has gone all in on the stock market recovery, investing every penny at his disposal. Despite the recent strong ...

The ruling, seen as a major victory for transparency campaigners, piles pressure on Ursula von der Leyen over the opaque nature of the EU's vaccine negotiations during the pandemic.

Lupus, an autoimmune disease affecting at least 5 million people worldwide and disproportionately impacting women, presents daily challenges for 30 to 50 out of every 100,000 individuals in the ...

Food allergy in children with atopic dermatitis is associated with an increased risk for asthma, allergic rhinitis, and ...

In 2024 alone, Singapore secured S$13.5 billion in fixed asset investment commitments, with the biomedical sector ...

President Donald Trump has signed a sweeping executive order to cut US prescription drug prices by up to 80%, aligning costs ...

Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated ...

Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...

A new treatment approach significantly improves survival rates for patients with aggressive, inherited breast cancers, according to researchers. In a trial where cancers were treated with chemotherapy ...